CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC [Phase 2]
Summary
A Phase II prospective trial evaluating reintroduction of mXELOXIRI for unresectable metastatic colorectal carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Unresectable Metastatic Colorectal Carcinoma | Phase 2 | Status: UNKNOWN